Thymoglobulin

also known as antithymocyte globulin · ATG · rabbit anti-thymocyte globulin · rATG · Anti-Thymocyte Globulin (Rabbit) · anti thymoglobulin · anti-thymocyte globulin (rabbit), thymoglobulin · rabbit anti-thymocyte globulin (ATG) · +9 more

Protein / enzyme biologic

Developed for: myelodysplastic syndrome · acute myeloid leukemia · transplant rejection · aplastic anemia · chronic myeloid leukemia · hematopoietic and lymphoid cell neoplasm · graft versus host disease · leukemia
+22 more
· acute lymphoblastic leukemia · cancer · chronic lymphocytic leukemia/small lymphocytic lymphoma · diabetes mellitus · Hodgkins lymphoma · kidney failure · plasma cell myeloma · acquired aplastic anemia · acute graft versus host disease · acute transplant rejection · autosomal genetic disease · end stage renal failure · engraftment syndrome · immunodeficiency disease · liver failure · metabolic disease · neuroblastoma · refractory plasma cell neoplasm · systemic sclerosis · Wiskott-Aldrich syndrome · impaired renal function disease · ischemic disease
Investigated by: Genzyme, a Sanofi Company · M.D. Anderson Cancer Center · The Korean Society of Pediatric Hematology Oncology · Peking University People's Hospital · University of Miami · Washington University School of Medicine
+47 more
· National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Novartis · Sanofi · The Cleveland Clinic · Amgen · Ann & Robert H Lurie Children's Hospital of Chicago · Barbara Ann Karmanos Cancer Institute · Belgian Hematological Society · Brigham and Women's Hospital · Columbia University · Coordinación de Investigación en Salud, Mexico · Emory University · Georgetown University · Hoffmann-La Roche · Hospices Civils de Lyon · Hospital Geral de Fortaleza · Hospital de Santa Maria, Portugal · Hospital do Rim e Hipertensão · Institut Paoli-Calmettes · Instituto de Investigación Hospital Universitario La Paz · Johns Hopkins University · Lahey Clinic · Masonic Cancer Center, University of Minnesota · Ministry of Health, France · Nagoya University · Nantes University Hospital · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · Providence Health & Services · Roche Pharma AG · St. Jude Children's Research Hospital · St. Paul's Hospital, Canada · St. Petersburg State Pavlov Medical University · Swedish Medical Center · The Hospital for Sick Children · The Methodist Hospital Research Institute · Unity Health Toronto · University Health Network, Toronto · University Hospital, Brest · University Hospital, Clermont-Ferrand · University of Arizona · University of Liege · University of Nebraska · University of Pittsburgh · Vastra Gotaland Region · Virginia Commonwealth University · Wake Forest University · Wright State University

Trials 56

today NCT07052370 · Ph 1 NCT06872333 · Ph 2 NCT06066255 · Ph 2 NCT05743400 · Ph 4 NCT03852407 · Ph 2 NCT03821987 · not/applicable NCT03793517 · Ph 2/3 NCT03006419 · Ph 4 NCT02877082 · Ph 2 NCT02544113 · Ph 2 NCT02627573 · Ph 2 NCT03088280 · Ph 4 NCT01856803 · Ph 4 NCT02083991 · Ph 4 NCT01556347 · Ph 2 NCT01844635 · Ph 3 NCT01566656 · Ph 2 NCT01354301 · Ph 4 NCT01246206 · Ph 2 NCT01280617 · not/applicable NCT01939171 · Ph 2 NCT01149993 · Ph 4 NCT00906204 · Ph 2 NCT01135537 · Ph 2 NCT00970073 · not/applicable NCT01028092 · Ph 3 NCT00882323 · Ph 2 NCT00709592 · Ph 2 NCT00714480 · not/applicable NCT00679536 · Ph 1/2 NCT00706680 · Ph 4 NCT00593645 · Ph 2 NCT00542828 · Ph 2 NCT00750126 · Ph 2 NCT00885833 · Ph 1/2 NCT00275509 · Ph 3 NCT00409695 · Ph 1/2 NCT00545519 · Ph 1 NCT00506948 · Ph 2 NCT00887042 · Ph 1/2 NCT00476229 · not/applicable NCT01172418 · Ph 4 NCT00737685 · Ph 2 NCT00235781 · not/applicable NCT00475020 · Ph 2 NCT00806598 · Ph 2 NCT00117689 · Ph 2 NCT00088543 · not/applicable NCT00670410 · Ph 1 NCT00089947 · Ph 2 NCT00062712 · Ph 2 NCT00685061 · Ph 4 NCT00681343 · Ph 4 NCT00040651 · Ph 1 NCT00006178 · Ph 2 NCT00235300 · Ph 2

20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028202920302031203220332034

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 14 trials
Phase 1	NCT07052370	Sep 2025 → Dec 2028 expected	hematopoietic and lymphoid system neoplasm	St. Jude Children's Research Hospital	Recruiting	No outcome recorded
Phase 1	NCT00545519	Oct 2006 → Mar 2008	refractory plasma cell neoplasm	Washington University School of Medicine	Completed	No outcome recorded
Phase 1	NCT00670410	Nov 2003 → Dec 2010	neuroblastoma	Columbia University	Terminated	No outcome recorded Stop: Enrollment
Phase 1	NCT00040651	Jul 2002 → Mar 2007	systemic sclerosis	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)	Terminated	No outcome recorded
Phase 1/24 trials
Phase 1/2	NCT00679536	May 2008 → May 2015	leukemia	Ann & Robert H Lurie Children's Hospital of Chicago	Unknown	No outcome recorded
Phase 1/2	NCT00885833	Feb 2007 → Mar 2012	Wiskott-Aldrich syndrome	The Korean Society of Pediatric Hematology Oncology	Completed	No outcome recorded
Phase 1/2	NCT00409695	Dec 2006 → Aug 2007	acute graft versus host disease	M.D. Anderson Cancer Center	Terminated	No outcome recorded Stop: Enrollment
Phase 1/2	NCT00887042	Jun 2006 → May 2012	acute myeloid leukemia	The Korean Society of Pediatric Hematology Oncology	Unknown	No outcome recorded
Phase 226 trials · 1 met primary · 2 missed
Phase 2	NCT06872333	Nov 2024 → Jun 2030 expected	disease related to hematopoietic stem cell transplant, sickle cell disease	Masonic Cancer Center, University of Minnesota	Recruiting	No outcome recorded
Phase 2	NCT06066255	Mar 2024 → Mar 2026	hematopoietic and lymphoid cell neoplasm	Institut Paoli-Calmettes	Unknown	No outcome recorded
Phase 2	NCT03852407	Feb 2019 → Nov 2033 expected	Hodgkins lymphoma, acute lymphoblastic leukemia, acute myeloid leukemia, chronic myeloid leukemia +2	University of Liege	Recruiting	No outcome recorded
Phase 2	NCT02877082	Sep 2016 → Jul 2017	chronic lymphocytic leukemia/small lymphocytic lymphoma, chronic myeloid leukemia, diffuse large B-cell lymphoma, follicular lymphoma +5	Emory University	Terminated	No outcome recorded
Phase 2	NCT02544113	Dec 2015 → Jun 2018	liver failure	The Cleveland Clinic	Completed	Missed primary
Phase 2	NCT02627573	Jul 2015 → Apr 2019	atypical chronic myeloid leukemia, BCR-ABL1 negative, chronic myeloid leukemia, myelodysplastic syndrome	St. Petersburg State Pavlov Medical University	Terminated	No outcome recorded Stop: Enrollment
Phase 2	NCT01556347	Jul 2012 → May 2016	—	Providence Health & Services	Terminated	No outcome recorded
Phase 2	NCT01566656	Mar 2012 → Nov 2016	hematopoietic and lymphoid cell neoplasm	Nantes University Hospital	Completed	No outcome recorded
Phase 2	NCT01246206	Nov 2010 → Oct 2013	hematopoietic and lymphoid cell neoplasm	Barbara Ann Karmanos Cancer Institute	Completed	No outcome recorded
Phase 2	NCT01939171	Jun 2010 → Feb 2012	—	Instituto de Investigación Hospital Universitario La Paz	Completed	No outcome recorded
Phase 2	NCT00906204	Mar 2010 → Jul 2014	end stage renal failure, kidney failure	Wright State University	Completed	Met primary
Phase 2	NCT01135537	Nov 2009 → Jan 2014	autosomal genetic disease, cancer, metabolic disease	The Hospital for Sick Children	Terminated	No outcome recorded
Phase 2	NCT00882323	Nov 2008 → Oct 2012	aplastic anemia	The Korean Society of Pediatric Hematology Oncology	Unknown	No outcome recorded
Phase 2	NCT00709592	Jul 2008 → Feb 2014	Hodgkins lymphoma, acute myeloid leukemia, chronic lymphocytic leukemia/small lymphocytic lymphoma, chronic myeloid leukemia +2	Virginia Commonwealth University	Completed	No outcome recorded
Phase 2	NCT00593645	Nov 2007 → Dec 2008	acute myeloid leukemia, myelodysplastic syndrome	Washington University School of Medicine	Terminated	No outcome recorded
Phase 2	NCT00542828	Oct 2007 → May 2009	myelodysplastic syndrome	Genzyme, a Sanofi Company	Terminated	No outcome recorded Stop: Enrollment
Phase 2	NCT00750126	Apr 2007 → Apr 2009	cancer, hematopoietic and lymphoid cell neoplasm	University Hospital, Clermont-Ferrand	Unknown	No outcome recorded
Phase 2	NCT00506948	Sep 2006 → Oct 2010	leukemia, lymphoma, myelodysplastic syndrome	M.D. Anderson Cancer Center	Terminated	No outcome recorded
Phase 2	NCT00475020	Jan 2006 → Oct 2017	myelofibrosis	M.D. Anderson Cancer Center	Completed	No outcome recorded
Phase 2	NCT00737685	Jan 2006 → Aug 2012	aplastic anemia	The Korean Society of Pediatric Hematology Oncology	Unknown	No outcome recorded
Phase 2	NCT00806598	May 2005 → Jun 2012	aplastic anemia, myelodysplastic syndrome	M.D. Anderson Cancer Center	Completed	No outcome recorded
Phase 2	NCT00117689	Apr 2005 → Dec 2007	liver disorder, transplant rejection	Genzyme, a Sanofi Company	Completed	No outcome recorded
Phase 2	NCT00062712	Jun 2003 → Mar 2007	—	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	Completed	No outcome recorded
Phase 2	NCT00089947	Jun 2003 → Dec 2005	transplant rejection	Genzyme, a Sanofi Company	Completed	No outcome recorded
Phase 2	NCT00006178	Aug 2000 → Dec 2007	kidney failure	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	Completed	No outcome recorded
Phase 2	NCT00235300	May 2000 → Apr 2003	acute transplant rejection	Genzyme, a Sanofi Company	Completed	Missed primary

Phase 2/31 trial
Phase 2/3	NCT03793517	Sep 2018 → Oct 2023 overdue	acute myeloid leukemia, disease related to hematopoietic stem cell transplant	Peking University People's Hospital	Recruiting	No outcome recorded
Phase 33 trials
Phase 3	NCT01844635	May 2012 → May 2016	acquired aplastic anemia	Nagoya University	Unknown	No outcome recorded
Phase 3	NCT01028092	Mar 2009 → Mar 2014	—	University Hospital, Brest	Completed	No outcome recorded
Phase 3	NCT00275509	Jan 2007 → Jun 2010	chronic renal failure syndrome	Johns Hopkins University	Completed	No outcome recorded
Phase 411 trials · 2 met primary · 1 missed
Phase 4	NCT05743400	Sep 2023 → Apr 2025 overdue	thrombotic microangiopathy	Hospices Civils de Lyon	Recruiting	No outcome recorded
Phase 4	NCT03006419	Dec 2016 → Jul 2019	transplant rejection	Coordinación de Investigación en Salud, Mexico	Completed	No outcome recorded
Phase 4	NCT03088280	Jun 2015 → Jan 2018	—	Hospital Geral de Fortaleza	Unknown	No outcome recorded
Phase 4	NCT01856803	Oct 2013 → Jun 2018	graft versus host disease	Peking University People's Hospital	Completed	Met primary
Phase 4	NCT02083991	Jan 2013 → Jan 2017	diabetes mellitus	Vastra Gotaland Region	Completed	No outcome recorded
Phase 4	NCT01354301	May 2011 → Apr 2014	cytomegalovirus infection, transplant rejection	Hospital do Rim e Hipertensão	Completed	Met primary
Phase 4	NCT01149993	Jun 2010 → Jun 2012	—	Georgetown University	Withdrawn	No outcome recorded
Phase 4	NCT00706680	Feb 2008 → Feb 2009	diabetes mellitus, transplant rejection	University Health Network, Toronto	Unknown	No outcome recorded
Phase 4	NCT01172418	Feb 2006 → May 2010	—	University of Miami	Completed	Missed primary
Phase 4	NCT00685061	Nov 2002 → Sep 2004	—	University of Miami	Completed	No outcome recorded
Phase 4	NCT00681343	Sep 2002 → Oct 2006	—	University of Miami	Completed	No outcome recorded

Phase not applicable7 trials · 1 met primary
—	NCT03821987	Dec 2018 → Dec 2021	aplastic anemia, engraftment syndrome	Peking University People's Hospital	Unknown	No outcome recorded
—	NCT01280617	Oct 2010 → Nov 2013	acute kidney injury	Lahey Clinic	Completed	Met primary
—	NCT00970073	Aug 2009 → Jun 2015	—	The Cleveland Clinic	Completed	No outcome recorded
—	NCT00714480	Jul 2008 → Dec 2009	immunodeficiency disease	Swedish Medical Center	Completed	No outcome recorded
—	NCT00476229	Jun 2006 → May 2009	leukemia, lymphoma	M.D. Anderson Cancer Center	Completed	No outcome recorded
—	NCT00235781	Jan → Feb 2006	—	Washington University School of Medicine	Terminated	No outcome recorded
—	NCT00088543	Mar 2004 → Apr 2006	acute lymphoblastic leukemia, acute myeloid leukemia, graft versus host disease	Genzyme, a Sanofi Company	Completed	No outcome recorded
Comparator or background therapy59 trials
Phase 1	NCT05298358 Background	Nov 2022 → Nov 2024	systemic sclerosis	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	Terminated	No outcome recorded Stop: Enrollment
Phase 1	NCT02512497 Background	Dec 2017 → Oct 2023	T-cell large granular lymphocyte leukemia, T-cell prolymphocytic leukemia, peripheral T-cell lymphoma, not otherwise specified, primary cutaneous T-cell lymphoma	Ohio State University Comprehensive Cancer Center	Completed	No outcome recorded
Phase 1	NCT02867800 Background	Jul 2016 → Dec 2021	graft versus host disease, sickle cell disease	Monica Bhatia	Completed	No outcome recorded
Phase 1	NCT00402558 Background	May 2006 → Apr 2014	leukemia, myelodysplastic syndrome	M.D. Anderson Cancer Center	Completed	No outcome recorded
Phase 1	NCT00669890 Background	May 2004 → Dec 2012	acute myeloid leukemia, juvenile myelomonocytic leukemia, myelodysplastic syndrome	New York Medical College	Terminated	No outcome recorded
Phase 1	NCT00579709 Background	Jul 2002 → Dec 2006	DiGeorge syndrome	Sumitomo Pharma Switzerland GmbH	Completed	No outcome recorded
Phase 1/2	NCT07607197 Background	Feb 2024 → May 2027 expected	anti-HLA hyperimmunization, end stage renal failure	Hospital Universitari Vall d'Hebron Research Institute	Recruiting	No outcome recorded
Phase 1/2	NCT00303667 Background	Jan 2005 → Mar 2011	acute myeloid leukemia	Masonic Cancer Center, University of Minnesota	Completed	No outcome recorded
Phase 2	NCT06646497 Background	Jan 2025 → Jan 2030 expected	acquired aplastic anemia	Assistance Publique - Hôpitaux de Paris	Recruiting	No outcome recorded
Phase 2	NCT05735717 Background	May 2023 → Nov 2027 expected	CBL-related disorder, acute lymphoblastic leukemia, acute myeloid leukemia, central nervous system leukemia +6	Masonic Cancer Center, University of Minnesota	Recruiting	No outcome recorded
Phase 2	NCT04903054 Background	Jan → Sep 2022	disease related to solid organ transplantation	National Institute of Allergy and Infectious Diseases (NIAID)	Withdrawn	No outcome recorded Stop: Enrollment
Phase 2	NCT04888741 Comparator	Feb 2021 → Aug 2027 expected	Hodgkins lymphoma, acute lymphoblastic leukemia, acute myeloid leukemia, chronic myeloid leukemia +4	University of Birmingham	Recruiting	No outcome recorded
Phase 2	NCT04046549 Background	Oct 2019 → Jul 2022	transplant rejection	Amgen	Completed	No outcome recorded
Phase 2	NCT03292861 Comparator	Sep 2018 → Mar 2026 overdue	—	Cedars-Sinai Medical Center	Enrolling by invitation	No outcome recorded
Phase 2	NCT03219359 Background	Feb 2018 → Oct 2028 expected	Crohn disease	Aaron Etra	Recruiting	No outcome recorded
Phase 2	NCT02464878 Background	Jan 2017 → Nov 2022	type 1 diabetes mellitus	Massachusetts General Hospital	Completed	No outcome recorded
Phase 2	NCT02833805 Background	Sep 2016 → Jul 2021	aplastic anemia, bone marrow failure syndrome	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	Completed	No outcome recorded
Phase 2	NCT02776202 Background	May 2016 → Dec 2019	sickle cell disease	National Guard Health Affairs	Unknown	No outcome recorded
Phase 2	NCT02582775 Background	Mar 2016 → Nov 2022	epidermolysis bullosa	Masonic Cancer Center, University of Minnesota	Completed	No outcome recorded
Phase 2	NCT02137239 Background	Dec 2015 → May 2019	—	Bristol-Myers Squibb	Completed	No outcome recorded
Phase 2	NCT02495077 Background	Nov 2015 → Jul 2021	—	National Institute of Allergy and Infectious Diseases (NIAID)	Completed	Missed primary
Phase 2	NCT02441803 Background	Sep 2015 → Sep 2020	leukemia	M.D. Anderson Cancer Center	Completed	No outcome recorded
Phase 2	NCT02224872 Background	Aug 2014 → Dec 2021	aplastic anemia, bone marrow failure syndrome	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	Completed	No outcome recorded
Phase 2	NCT01490723 Background	Jan 2013 → Apr 2019	leukemia, lymphoma	M.D. Anderson Cancer Center	Completed	No outcome recorded
Phase 2	NCT01622556 Background	Jan 2012 → Feb 2014	hematopoietic and lymphoid system neoplasm	University of Virginia	Terminated	No outcome recorded
Phase 2	NCT01392989 Background	Mar 2011 → Jun 2016	anemia, myelodysplastic syndrome, myeloid leukemia, neural tube defect	Everett Meyer	Completed	Missed primary
Phase 2	NCT00990249 Background	Oct 2009 → May 2016	acute lymphoblastic leukemia	M.D. Anderson Cancer Center	Completed	No outcome recorded
Phase 2	NCT00916045 Background	Sep 2009 → Mar 2012	Hodgkins lymphoma, acute myeloid leukemia, chronic lymphocytic leukemia/small lymphocytic lymphoma, myelodysplastic syndrome	King's College Hospital NHS Trust	Terminated	No outcome recorded Stop: Enrollment
Phase 2	NCT00899431 Comparator	May 2009 → Oct 2018	B-cell chronic lymphocytic leukemia	M.D. Anderson Cancer Center	Terminated	No outcome recorded
Phase 2	NCT00857389 Background	Mar 2009 → Mar 2019	disease related to hematopoietic stem cell transplant, leukemia, lymphoma	M.D. Anderson Cancer Center	Completed	No outcome recorded
Phase 2	NCT00813124 Background	Dec 2008 → Sep 2014	disease related to hematopoietic stem cell transplant, leukemia	M.D. Anderson Cancer Center	Completed	No outcome recorded
Phase 2	NCT00523809 Background	Aug 2007 → Oct 2011	breast cancer, ovarian cancer	M.D. Anderson Cancer Center	Terminated	No outcome recorded Stop: Enrollment
Phase 2	NCT00455013 Background	Jul 2007 → Oct 2008	disease related to solid organ transplantation	Bristol-Myers Squibb	Completed	No outcome recorded
Phase 2	NCT00469014 Background	Sep 2006 → Mar 2013	acute myeloid leukemia, chronic myeloid leukemia, myelodysplastic syndrome	M.D. Anderson Cancer Center	Completed	No outcome recorded
Phase 2	NCT00506129 Background	Sep 2003 → Jun 2015	disease related to hematopoietic stem cell transplant, lymphoma	M.D. Anderson Cancer Center	Completed	No outcome recorded
Phase 2/3	NCT03799224 Background	Dec 2018 → Dec 2021	acute leukemia, disease related to hematopoietic stem cell transplant	Peking University People's Hospital	Unknown	No outcome recorded
Phase 2/3	NCT01087398 Background	Sep 2009 → Nov 2012	osteopetrosis	Tehran University of Medical Sciences	Unknown	No outcome recorded
Phase 3	NCT06083129 Comparator	Nov 2023 → Nov 2028 expected	graft versus host disease	Assistance Publique - Hôpitaux de Paris	Recruiting	No outcome recorded
Phase 3	NCT04302805 Comparator	Jul 2020 → Apr 2024	—	Institute for Clinical and Experimental Medicine	Completed	No outcome recorded
Phase 3	NCT01471444 Background	Nov 2011 → Dec 2020	disease related to hematopoietic stem cell transplant, leukemia	M.D. Anderson Cancer Center	Completed	No outcome recorded
Phase 3	NCT01157949 Comparator	Nov 2010 → Nov 2013	—	Cedars-Sinai Medical Center	Withdrawn	No outcome recorded
Phase 3	NCT00592306 Comparator	Jan 2006 → Sep 2009	—	University of California, Los Angeles	Withdrawn	No outcome recorded Stop: Enrollment
Phase 3	NCT00682292 Comparator	May 2001 → Nov 2006	—	University Hospital, Lille	Completed	No outcome recorded
Phase 4	NCT07203664 Background	Oct 2025 → Dec 2026 expected	—	Hospital Universitario La Paz	Not yet recruiting	No outcome recorded
Phase 4	NCT04009525 Background	Jul 2019 → Jul 2023	beta-thalassemia major	First Affiliated Hospital of Guangxi Medical University	Completed	No outcome recorded
Phase 4	NCT03470961 Comparator	Mar 2018 → Mar 2021	diabetes mellitus, end stage renal failure	Tianjin First Central Hospital	Unknown	No outcome recorded
Phase 4	NCT03171831 Background	Apr 2017 → Dec 2021	beta-thalassemia major	First Affiliated Hospital of Guangxi Medical University	Unknown	No outcome recorded
Phase 4	NCT02745717 Background	Jan 2016 → Dec 2021	aplastic anemia	Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine	Completed	No outcome recorded
Phase 4	NCT02447822 Comparator	Jun 2015 → May 2018	kidney failure	Asan Medical Center	Unknown	No outcome recorded
Phase 4	NCT02130817 Background	Sep 2014 → Oct 2015	end stage renal failure, transplant rejection	University of Wisconsin, Madison	Withdrawn	No outcome recorded Stop: Enrollment
Phase 4	NCT02683291 Background	Jan 2014 → Jan 2015	cytomegalovirus infection, disease related to solid organ transplantation	Associação Médico Espírita de Botucatu	Completed	No outcome recorded
Phase 4	NCT01895049 Comparator	Aug 2013 → Mar 2016	cytomegalovirus infection	Helio Tedesco Silva Junior	Completed	Met primary
Phase 4	NCT02084446 Background	Dec 2012 → Jul 2014	cytomegalovirus infection, disease related to solid organ transplantation	Ronaldo de Matos Esmeraldo, MD	Completed	No outcome recorded
Phase 4	NCT01312064 Comparator	Apr 2011 → Apr 2012	impaired renal function disease	National Taiwan University Hospital	Terminated	No outcome recorded
Phase 4	NCT00771745 Comparator	Sep 2008 → Jun 2010	transplant rejection	University of Cincinnati	Completed	No outcome recorded
Phase 4	NCT01195194 Background	Mar 2008 → Jun 2012	disease related to solid organ transplantation	Josep M Grinyo	Completed	No outcome recorded
Phase 4	NCT01046955 Comparator	Nov 2005 → Apr 2007	end stage renal failure	University of Miami	Completed	No outcome recorded
—	NCT01850108 Background	May 2013 → Nov 2023	sickle cell disease	Vanderbilt-Ingram Cancer Center	Unknown	No outcome recorded
—	NCT00709293 Comparator	Jul 2008 → May 2009	ischemic disease	University of California, Los Angeles	Withdrawn	No outcome recorded Stop: Business

Evidence & citations 21 cited values

Every value below carries the sentence it was read from. 118 sources stand behind the page.

Field	Value	Cited text
Known as	Thymoglobulin	“A Study to Compare the Effectiveness of a Drug That Suppresses the Immune System Called Thymoglobulin® in Preventing the Development of a Disease That Affects the Majority of...” NCT01157949 ↗ 117 “A prominent example of this class of drugs is Thymoglobulin(TMG), a purified, pasteurized gamma immune globulin, which is obtained by immunization of rabbits with human thymocytes.” NCT00714480 ↗ “At our institution, one such antibody preparation (Thymoglobulin) is used in most pediatric heart transplant recipients for 3-5 days immediately after transplantation.” NCT00709293 ↗ “Children over two years and adults undergoing a first hematopoietic stem cell transplantation will receiveThymoglobulin® as part of the conditioning.” NCT05743400 ↗ “All patients will start with Thymoglobulin 1 mg/kg before transplant followed by 0,5 mg/kg/d during the next 5 days (total accumulated 3,5 mg/kg).” NCT01195194 ↗ “Two randomized groups of kidney transplant recipients will be each administered the drug Thymoglobulin according to a different dosing regimen.” NCT00906204 ↗ “ATG: Thymoglobulin will be administered five times intravenously at 1.5 mg/kg/day from day -11 through day -7 for a total dose of 7.5 mg/kg.” NCT01566656 ↗ “The two commonly used ATGs, Thymoglobulin and ATG-F have slightly different antigen profile and antibody concentrations.” PMID 27855166 ↗ Nov 2016 “Patients receive immunosuppressive induction treatment with thymoglobulin (at least 1 dose and maximum of 5 doses)” NCT07203664 ↗ “Conditioning regimen Thymoglobulin (0.5/mg/kg à D-9, 2 mg /kg at D-8 and 2.5 mg/kg à D-7)” NCT06646497 ↗ “Thymoglobulin Versus Alemtuzumab Versus Daclizumab in Living Donor Renal Transplantation” NCT01046955 ↗ Show 107 more sources
Known as	anti thymoglobulin	“Drug: anti thymoglobulin” NCT01856803 ↗
Known as	Anti-Thymocyte Globulin (Rabbit)	“Thymoglobulin [Anti-Thymocyte Globulin (Rabbit)]” NCT00088543 ↗ 1 “Thymoglobulin [Anti-Thymocyte Globulin (Rabbit)]” NCT00089947 ↗
Known as	anti-thymocyte globulin (rabbit), thymoglobulin	“anti-thymocyte globulin (rabbit), thymoglobulin” NCT00771745 ↗
Known as	antithymocyte globulin	“Rabbit antithymocyte globulin (rATG, Thymoglobulin®) is the most common induction immunosuppression therapy in kidney transplantation.” PMID 26285695 ↗ Aug 2015 3 “comparing antithymocyte globulin (Thymoglobulin) (group A, N=43) versus alemtuzumab (group B, N=43) versus daclizumab (group C, N=42)” PMID 24477186 ↗ Jun 2014 “Thymoglobulin, rabbit derived antithymocyte globulin (Thymoglobulin, SangStat, Fremont, CA)” NCT00235781 ↗ “Thymoglobulin (anti-thymocyte globulin)” NCT01149993 ↗
Known as	ATG	“rabbit anti-thymocyte globulin (ATG) (Thymoglobuline, Genzyme)” NCT01844635 ↗ 3 “ATG (thymoglobulin; Sang Stat, France)” NCT03799224 ↗ “Thymoglobulin (ATG)” NCT00469014 ↗ “ATG” NCT01490723 ↗
Known as	rabbit anti-thymocyte globulin	“Rabbit antithymocyte globulin (rATG, Thymoglobulin®) is the most common induction immunosuppression therapy in kidney transplantation.” PMID 26285695 ↗ Aug 2015 2 “Thymoglobulin (rabbit antithymocyte globulin) is FDA approved for the treatment of acute cellular rejection.” NCT01280617 ↗ “rabbit anti-thymocyte globulin (ATG) (Thymoglobuline, Genzyme)” NCT01844635 ↗
Known as	rabbit anti-thymocyte globulin (ATG)	“Thymoglobulin® (Genzyme) \[rabbit anti-thymocyte globulin (ATG)\]” NCT03292861 ↗
Known as	Rabbit Anti-thymocyte Globulin (rATG)	“Thymoglobulin®, Rabbit Anti-thymocyte Globulin (rATG)” NCT00542828 ↗
Known as	rabbit Thymoglobulin (r-ATG)	“rabbit Thymoglobulin (r-ATG)” NCT02084446 ↗
Known as	rabbitATG	“The patient will also receive Thymoglobulin (rabbitATG) on Day -4 to Day -2.” NCT00679536 ↗
Known as	rATG	“Rabbit antithymocyte globulin (rATG, Thymoglobulin®) is the most common induction immunosuppression therapy in kidney transplantation.” PMID 26285695 ↗ Aug 2015 2 “thymoglobulin (A :rATG ,Sang Stat,France) 2.5mg/kg/dx4d” NCT03821987 ↗ “rabbit Thymoglobulin (rATG)” NCT07607197 ↗
Known as	rATG (rabbit antithymocyte globulin)	“rATG (rabbit antithymocyte globulin)” NCT01172418 ↗
Known as	Sang Stat	“thymoglobulin (A :rATG ,Sang Stat,France) 2.5mg/kg/dx4d” NCT03821987 ↗
Known as	Thymo-S	“All patients received rATG for 4 days [ATG-Fresenius (ATG-F) 4 mg/kg/day or Thymoglobulin (Thymo-S) 1.25 mg/kg/day] plus MMF and short-term corticosteroids.” PMID 15814548 ↗ May 2005
Known as	Thymoglobulin, Genzyme	“Thymoglobulin, Genzyme” NCT00682292 ↗
Known as	Thymoglobuline	“rabbit anti-thymocyte globulin (ATG) (Thymoglobuline, Genzyme)” NCT01844635 ↗
Known as	TMG	“A prominent example of this class of drugs is Thymoglobulin(TMG), a purified, pasteurized gamma immune globulin, which is obtained by immunization of rabbits with human thymocytes.” NCT00714480 ↗
Action	Deplete	“thymoglobulin to kill the T-cells” NCT00040651 ↗
Modality	Protein / enzyme biologic	“a FDA-approved polyclonal rabbit-IgG antithymocyte preparation” NCT00006178 ↗
Route	Intravenous	“Thymoglobulin will be given intravenously” NCT00006178 ↗